2Kanazawa H, Kurihara N, Otsuka T,et al. Clinical significance of serum concentration of interleukin 8 in patients with bronchial asthma or chronic pulmonary emphysema. Respiration, 1996,63:236-402.
3Aaron SD, Angel JB, Lunau M,et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2001,163:349-355.
4De Boer W. Cytokines and therapy in COPD. Chest, 2002,121:209-218.
5Isabelle P, Peter GG, Roxanne K, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax, 1992,47:25 -29.
6Hill AT, Bayley D, Slockley RA, et al. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med, 1999, 160: 893-898.
9Keatings VM. Differences in interleuking-8 and tumor necrosis factor-alpha in induced Sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med, 1996,153:530-534.
10Martin J, Tohin MJ. Chronic obstructive pulmonary disease, pollution,pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2002. Am J Respir Crit Care Med, 2003,167:356-370.
2Katherine JB, Jodie LS, Peter GG, et al. Innate Immune Respon- ses Are Increased in Chronic Obstructive Pulmonary Disease [ J ]. Incrs Inn Inmn Resps in COPD, 2011, 6(3) : 1 -7.
3Stefan Rfipcke, Olaf Holz, Gereon Lauer, et al. Repeatability of and Relationship between Potential COPD Biomarkers in Bronchoal- veolar Lavage, Bronchial Biopsies [J]. Serum, and Induced Spu- tum, 2012, 7(10): 1-11.
4Vestbo J, Rennard S. Chronic obstructive pulmonary disease bio- marker for disease activity needed-urgently [ J]. Am J Respir Crit Care Med, 2010, 182(2) : 863 -864.
5Agusti A, Edwards LD, Rennard SI. Persistent systemic inflamma- tion is associated with poor clinical outcomes in COPD : a novel phe- notype [J]. 2012, 114(3): 1655-1661.
6Jan S, Katarzyna B, ]acek L, et al. The effect of physiotherapy on interleukin-8 levels in patients with chronic obstructive pulmonary disease [ J ]. Pneumonologia i Alergologia Polska, 2011 , 79 ( 3 ) : 184 - 188.
7Davidson WJ, Verity WS, Traves SL, et al. Effect of incremental exercise on airway and systemic inflammation in patients with COPD [J]. J Appl Physiol, 2012, 112(12) : 2049 -2056.
8Armstrong J, Hm'bron C, Lea S, et al. Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophage from patients with chronic obstructive pulmona- ry disease [J]. J Pharmacol Exp Ther, 2011, 338( 12): 732- 740.
